Braftovi Regimen Is Promising in Metastatic Colorectal Cancer
WEB20 hours ago · The BREAKWATER trial assessed the combination of Braftovi and Erbitux with or without chemotherapy in patients with metastatic colorectal cancer. Patients must have confirmed stage 4 colorectal cancer harboring a BRAF V600E mutation. Patients were ineligible if they had tumors that are microsatellite instability-high or …
CURE - Oncology & Cancer News for Patients & Caregivers
WEBBoruzu Approved by FDA For Multiple Myeloma, Mantle Cell Lymphoma. By Alex Biese. September 6th 2024. CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
Infections May Impact Survival, Quality of Life in Patients With MDS
WEB18 hours ago · Researchers also listed what they found to be the risk factors for infections and adverse outcomes in patients with MDS: Neutropenia. Advanced age. Co-morbidities. Frailty. ECOG performance status (patients’ ability to perform daily tasks) Hypoalbuminemia (low levels of albumin in the blood) Having higher-risk MDS.
Healing and Reflecting on My Ovarian Cancer Experience
WEB1 day ago · The past 15 months have been challenging regarding treatment for my ovarian cancer. But today, my goal is to focus on healing my mind, body and soul. When I look back to the blog posts that I have written for CURE®, I realize that it has been since July of 2023 when I last shared my cancer experience. There were many challenging reasons for this.
Therapies for Some With Prostate Cancer Focuses on Reducing …
WEB3 days ago · Loaded 0%. Newer treatments for metastatic hormone-sensitive prostate cancer like Nubeqa (darolutamide) are being developed to potentially reduce side effects like cognitive impairment and fatigue, an expert said. CURE® sat down with Dr. Fred Saad, director of prostate cancer research at Montreal Cancer Institute and full professor in the ...
Choices About Cancer Treatment During a Tumultuous Time
WEBSep 12, 2024 · Receiving a cancer diagnosis at any age is a life-altering experience, but for adolescents and young adults (AYAs) already navigating a potentially tumultuous time of life, the challenges can be amplified. In this seasonal issue of CURE, we look at the stories of AYA patients such as Stacy Leung who, at just 23 years old, received a diagnosis ...
All News - Curetoday
WEBRoger O’Donnell Has Lymphoma, ‘Love Is Blind’ Star Reveals Cancer During Pregnancy and More. Ashley Chan; Brielle Benyon. September 6th 2024. From Roger O’Donnell announcing his aggressive lymphoma diagnosis to “Love Is Blind’s” Shaina Hurley opening up about her cervical cancer while three months pregnant, here’s what’s ...
CURE Fall 2022 - Curetoday
WEBA Shift in Focus for Head and Neck Cancer Treatment. Marijke Vroomen Durning, RN. September 20th 2022. Article Feature. Years ago, the goal of head and neck cancer treatment was strictly focused on a cure. Now, there has been a slight change in approach to improve survival rates while preserving quality of life.
Prostate Cancer | Oncology & Cancer News | Tumor | CURE
WEBMay 24th 2024. From Michael Richards revealing his prostate cancer diagnosis to MLB Hall-of-Famer Ryne Sandberg being cancer-free, here’s what’s happening in the oncology space this week. Lymph Node Radiation Reduced Death in Young Patients with Prostate Cancer. Alex Biese.
CURE® Winter 2021 - Curetoday
WEBJanuary 11th 2021. Article. Patients older than 75 years experienced more toxicity with mTOR inhibitors, tyrosine kinase inhibitors and checkpoint immunotherapy compared with those younger than 75 years, but researchers found that age did not impact outcomes like progression-free survival and overall survival.